Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Glenn J Hanna, M.D.

Concepts (232)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Oropharyngeal Neoplasms1320234754.280 Why?
Head and Neck Neoplasms25202327124.090 Why?
Carcinoma, Adenoid Cystic720232523.950 Why?
Carcinoma, Squamous Cell21202440292.930 Why?
Papillomavirus Infections14202415852.870 Why?
Mouth Neoplasms920246012.280 Why?
Salivary Gland Neoplasms320232971.300 Why?
Papillomaviridae9202211181.280 Why?
Neoplasm Recurrence, Local15202391851.120 Why?
Saliva220198050.940 Why?
Skin Neoplasms8202456620.850 Why?
Neoadjuvant Therapy6202327210.800 Why?
Sjogren's Syndrome120212290.700 Why?
Class I Phosphatidylinositol 3-Kinases420238900.690 Why?
Precancerous Conditions220249710.680 Why?
Proto-Oncogene Proteins c-bcl-6120191930.650 Why?
Antineoplastic Agents82023136550.640 Why?
Tretinoin120215160.640 Why?
Chromosomes, Human, Pair 3120193230.630 Why?
Leukoplakia, Oral32024730.600 Why?
Carcinoma, Merkel Cell420222990.590 Why?
Immunotherapy8202444140.590 Why?
Quinolones120203660.580 Why?
Genomics6202056920.580 Why?
DNA, Viral4202322240.530 Why?
Iodine Radioisotopes1201810300.480 Why?
Proto-Oncogene Proteins p21(ras)2202316830.470 Why?
Antineoplastic Combined Chemotherapy Protocols62022114720.470 Why?
Carcinoma, Neuroendocrine120183250.470 Why?
Phosphatidylinositol 3-Kinases4202129380.460 Why?
Kidney Transplantation3202442460.460 Why?
Genes, Tumor Suppressor1201810970.450 Why?
Immunophenotyping2201718660.440 Why?
Hematologic Neoplasms1202318200.400 Why?
Hypopharyngeal Neoplasms12011500.400 Why?
Residence Characteristics1202120490.390 Why?
Solitary Fibrous Tumors12011720.370 Why?
Humans7920247420880.370 Why?
Aged, 80 and over202022576830.350 Why?
Survival Analysis62020102480.350 Why?
Middle Aged3520242131270.350 Why?
CD8-Positive T-Lymphocytes3202344380.350 Why?
Alphapapillomavirus220222210.340 Why?
Aged3020221629440.320 Why?
Hemangiosarcoma120112360.320 Why?
Prognosis102021290100.320 Why?
Neoplasm Metastasis6202148390.310 Why?
Survivors1201822860.300 Why?
Tumor Microenvironment4202435640.300 Why?
Breast Diseases120114430.300 Why?
Thyroid Neoplasms2201822740.290 Why?
Drug Resistance, Neoplasm3201851630.280 Why?
Hematoma120117550.270 Why?
Antibodies, Viral1201731640.260 Why?
Neoplasms72022215960.260 Why?
Male3320243495380.260 Why?
DNA-Binding Proteins2201996390.250 Why?
Human papillomavirus 16220232620.240 Why?
Female3420243795920.230 Why?
High-Throughput Nucleotide Sequencing4202035850.230 Why?
Adult2120212137120.220 Why?
Adrenal Cortex Hormones2202418470.220 Why?
Protein-Arginine N-Methyltransferases120231310.220 Why?
Treatment Outcome102021629660.200 Why?
Oncogene Proteins, Viral120233620.200 Why?
Transcription Factors32022121640.190 Why?
Hospitalization12020102320.190 Why?
Vascular Endothelial Growth Factor Receptor-2120235440.190 Why?
Prospective Studies102024531870.190 Why?
Hematopoietic Stem Cell Transplantation1201854250.180 Why?
Anus Neoplasms120243320.180 Why?
Tumor Burden3202119050.170 Why?
Keratosis12019810.170 Why?
Lip120201950.170 Why?
Patient Selection2202342140.170 Why?
Breast Neoplasms22020207740.160 Why?
Aggression120237530.160 Why?
Disease Progression42023132560.160 Why?
Neoplasm Proteins3201836910.150 Why?
Combined Modality Therapy4202386210.150 Why?
Retrospective Studies172024770980.150 Why?
Chloride Channels120182250.150 Why?
Prostatic Neoplasms12020110390.150 Why?
Tumor Virus Infections120204510.150 Why?
Osteoradionecrosis12017490.140 Why?
Mutation82020297170.140 Why?
Genetic Predisposition to Disease12018174000.140 Why?
Microsatellite Repeats120188000.140 Why?
Hyperbaric Oxygenation120171630.140 Why?
Frameshift Mutation120183990.140 Why?
Radiotherapy, Intensity-Modulated120228060.130 Why?
Neoplasm Staging52023110010.130 Why?
Cohort Studies52021404500.130 Why?
Salvage Therapy1202112690.130 Why?
DNA3202472890.120 Why?
Oncogenes1202012630.120 Why?
Otorhinolaryngologic Surgical Procedures120183120.120 Why?
Young Adult62020563500.120 Why?
Oncogene Proteins120187490.120 Why?
Gene Dosage1201812510.120 Why?
Disease-Free Survival2202168910.120 Why?
TOR Serine-Threonine Kinases3202321070.110 Why?
Geriatric Assessment1202013690.110 Why?
Vascular Endothelial Growth Factor A1202335020.110 Why?
Urban Population1202020180.110 Why?
Drug Synergism1201617910.110 Why?
Myringoplasty12011120.100 Why?
Interferon-gamma1202031990.100 Why?
Androgen Antagonists1202013500.100 Why?
Radiosurgery1202113090.100 Why?
Molecular Targeted Therapy2202027230.090 Why?
Middle Ear Ventilation12011930.090 Why?
DNA Copy Number Variations1201919400.090 Why?
Carcinoma1202223740.090 Why?
Receptor, erbB-21202024100.090 Why?
Rural Population1202022070.090 Why?
Lymphatic Metastasis2201529060.090 Why?
Radiotherapy Dosage3202228760.090 Why?
Feasibility Studies1201950620.090 Why?
DNA Mutational Analysis1201841870.080 Why?
Medical Oncology1202022350.080 Why?
Nuclear Proteins2202258510.080 Why?
Gene Expression Profiling2202194100.080 Why?
Sirolimus1201415620.070 Why?
Graft Rejection1202043930.070 Why?
Sarcoma1201818950.070 Why?
Survival Rate22021127730.070 Why?
Neoplasms, Radiation-Induced120115460.070 Why?
Genome, Human1202044200.070 Why?
Incidence32020209280.070 Why?
Pilot Projects1201982970.070 Why?
Comorbidity12020103720.070 Why?
Biopsy1201867560.070 Why?
SEER Program2202015070.060 Why?
Tumor Suppressor Proteins1201428420.060 Why?
Logistic Models12019134030.060 Why?
Carcinoma, Ductal, Breast1201111010.060 Why?
Neoplasms, Second Primary1201110520.050 Why?
Lipid A12022670.050 Why?
Radiotherapy Planning, Computer-Assisted2202216220.050 Why?
Oncogene Proteins, Fusion2202215810.050 Why?
Cross-Sectional Studies12022249130.050 Why?
Clinical Trials as Topic1201779010.050 Why?
Parotid Gland120221680.050 Why?
Organs at Risk120223460.040 Why?
Histone Demethylases120223200.040 Why?
Quality of Life12020127300.040 Why?
Toll-Like Receptor 4120225610.040 Why?
Cell Cycle Proteins2202234440.040 Why?
Education, Medical, Graduate1201122830.040 Why?
Kaplan-Meier Estimate2202065340.040 Why?
Methylprednisolone120203880.040 Why?
Cell Transformation, Viral120205650.040 Why?
Hypokalemia120191530.040 Why?
Mucositis120191010.040 Why?
Signal Transduction22018233870.040 Why?
Virus Integration120202970.040 Why?
Clinical Trials, Phase II as Topic120206270.040 Why?
Jaw12017960.040 Why?
Maximum Tolerated Dose120198910.040 Why?
Time-Lapse Imaging120171950.040 Why?
raf Kinases120161220.040 Why?
Genome, Viral120206670.030 Why?
Workflow120218460.030 Why?
Spheroids, Cellular120173510.030 Why?
Clinical Competence1201146810.030 Why?
Prednisone1202015670.030 Why?
Diagnosis, Differential12011129580.030 Why?
Sex Distribution1202022950.030 Why?
Cytokines2202273170.030 Why?
Radiotherapy, Adjuvant1202017690.030 Why?
MAP Kinase Kinase Kinases120162610.030 Why?
Follow-Up Studies12017390040.030 Why?
Sensitivity and Specificity22020147200.030 Why?
Lymphocytes, Tumor-Infiltrating1202010380.030 Why?
Receptor, Notch212015890.030 Why?
Age Distribution1202029000.030 Why?
ras GTPase-Activating Proteins120151010.030 Why?
Quality-Adjusted Life Years1202016790.030 Why?
Cisplatin1202016370.030 Why?
Postoperative Period1201918390.030 Why?
Age of Onset1202032660.030 Why?
Radiation Dosage1202219270.030 Why?
Genetic Heterogeneity120167320.030 Why?
Gene Rearrangement1201811790.030 Why?
Phylogeny1202027970.030 Why?
Immunity1201810110.030 Why?
In Situ Hybridization, Fluorescence1201826380.030 Why?
Diarrhea1201913430.030 Why?
Immunologic Factors1202115750.030 Why?
Chemotherapy, Adjuvant1202034710.030 Why?
Receptor, Notch1120155020.030 Why?
Analysis of Variance1202063650.030 Why?
Cyclin-Dependent Kinase Inhibitor p16120157040.030 Why?
Income1202019040.020 Why?
Lymph Nodes1202334650.020 Why?
Drug Administration Schedule1201949290.020 Why?
Microfluidic Analytical Techniques120178280.020 Why?
Cell Line, Tumor22017166650.020 Why?
Cell Culture Techniques1201716700.020 Why?
Adolescent12018856490.020 Why?
Tumor Cells, Cultured1201763130.020 Why?
Killer Cells, Natural1201821330.020 Why?
Societies, Medical1202037400.020 Why?
Tomography, X-Ray Computed22023200860.020 Why?
Recurrence1202083330.020 Why?
Models, Educational120113770.020 Why?
United States32020696930.020 Why?
Computational Biology1202035180.020 Why?
Flow Cytometry1201759750.020 Why?
Proto-Oncogene Proteins B-raf1201620280.020 Why?
Protein Conformation1201440130.020 Why?
Statistics, Nonparametric1201128850.020 Why?
Antibodies, Monoclonal1202292740.020 Why?
Genotype12020129460.020 Why?
Longitudinal Studies12020139210.020 Why?
Reproducibility of Results12023198620.020 Why?
Tumor Suppressor Protein p531201529480.020 Why?
Educational Measurement1201112060.010 Why?
Case-Control Studies12022217190.010 Why?
Immunohistochemistry12017113630.010 Why?
Smoking1202089690.010 Why?
Magnetic Resonance Imaging22021353420.010 Why?
Sequence Analysis, DNA1201548010.010 Why?
Base Sequence12015127970.010 Why?
Radiography1201470100.010 Why?
Practice Guidelines as Topic1202072760.010 Why?
Gene Expression Regulation, Neoplastic1201884250.010 Why?
Polymorphism, Single Nucleotide12020154940.010 Why?
Internship and Residency1201157740.010 Why?
Mice12017810450.010 Why?
Animals120171685610.000 Why?
Hanna's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (232)
Explore
_
Co-Authors (171)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.